List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 53 studies with search of:   "Carbidopa"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-Motor Symptoms in Patients With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa/levodopa/entacapone, IR carbidopa/levodopa;   Drug: Carbidopa/levodopa/entacapone, IR carbidopa/levodopa
2 Terminated Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-Dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/levodopa;   Drug: Carbidopa/Levodopa/Entacapone
3 Not yet recruiting Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects  
Condition: Advanced Parkinson's Disease
Interventions: Drug: levodopa-carbidopa intestinal gel with placebo capsules;   Drug: levodopa-carbidopa intestinal placebo gel with active oral medication (capsules containing levodopa-carbidopa tablets);   Device: CADD-Legacy® 1400 ambulatory infusion pump
4 Not yet recruiting Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: levodopa-carbidopa intestinal gel with placebo capsules;   Drug: levodopa-carbidopa intestinal placebo gel with active oral medication (capsules containing levodopa-carbidopa tablets);   Device: CADD-Legacy® 1400 ambulatory infusion pump
5 Recruiting High and Low Dose Treatment of Carbidopa in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa-Levodopa;   Drug: Carbidopa- Levodopa
6 Recruiting Comparison of IPX054, Immediate-Release Carbidopa-Levodopa, and Controlled-Release Carbidopa-Levodopa in Subjects With Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: IPX054;   Drug: Carbidopa-levodopa immediate-release tablets;   Drug: Carbidopa-levodopa controlled-release tablets
7 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
8 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
9 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
10 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
11 Active, not recruiting Efficacy of Levodopa/Carbidopa/Entacapone vs. Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing Off
Condition: Parkinson's Disease
Intervention: Drug: Levodopa/carbidopa/entacapona
12 Recruiting Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-Carbidopa intestinal gel;   Device: CADD-Legacy® 1400
13 Not yet recruiting Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Parkinson's Disease;   Severe Motor Fluctuations;   Dyskinesia
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400
14 Completed An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/l-dopa;   Drug: carbidopa/l-dopa/entacapone;   Drug: Stalevo;   Procedure: [123I]-IBZM imaging
15 Not yet recruiting Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
16 Recruiting Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: levodopa-carbidopa
17 Completed A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Condition: Parkinson's Disease
Intervention: Drug: capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)
18 Terminated PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
Condition: Parkinson´s Disease
Interventions: Drug: entacapone and carbidopa;   Drug: Sinemet 200mg/50mg
19 Active, not recruiting Stalevo in Early Wearing-Off Patients
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Stalevo (levodopa/carbidopa/entacapone);   Drug: Levodopa/carbidopa
20 Completed Evaluating Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Carbidopa/Levodopa/Entacapone

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services